Yuan-Ting Cho

Yuan-Ting Cho is a prominent inventor based in Taipei, Taiwan. He has made significant contributions to the field of biotechnology, particularly in the development of novel compounds for therapeutic applications. With a total of 2 patents, his work focuses on addressing critical health issues through innovative chemical solutions.

Latest Patents

Yuan-Ting Cho's latest patents include groundbreaking research on heterocyclic pyrazole derivatives. These compounds serve as type III receptor tyrosine kinase inhibitors, which can effectively target protein kinases such as FLT3, PDGFRα, c-KIT, and CSF-1R. The potential applications of these inhibitors are vast, including treatments for various cancers, autoimmune diseases, and bone resorptive diseases. Another notable patent involves a regioselective one-step process for synthesizing 2-hydroxyquinoxaline, which showcases his expertise in chemical synthesis and innovation.

Career Highlights

Yuan-Ting Cho is affiliated with the Development Center for Biotechnology, where he continues to advance his research and development efforts. His work has not only contributed to the scientific community but also holds promise for improving patient outcomes in various medical conditions.

Collaborations

Yuan-Ting Cho collaborates with esteemed colleagues such as Shao-Zheng Peng and Pao-Chiung Hong. These partnerships enhance the scope and impact of his research, fostering a collaborative environment for innovation.

Conclusion

Yuan-Ting Cho's contributions to biotechnology through his patents and collaborative efforts highlight his role as a key innovator in the field. His work continues to pave the way for new therapeutic solutions that address pressing health challenges.

Profile summary based on public USPTO records.